Helicobacter pylori is the primary and proven cause of chronic gastritis and peptic ulcers (gastric and duodenal ulcers). Testing can provide a definitive diagnosis and avoid blind treatment
Long-term infection significantly increases the risk of gastric cancer and gastric mucosa-associated lymphoid tissue lymphoma. Eradication therapy is a primary preventive strategy for these malignancies.
For confirmed peptic ulcers, gastric MALT lymphoma, etc., testing and eradication of Helicobacter pylori are key steps in curing the disease.
Helicobacter pylori is primarily transmitted through oral-oral or fecal-oral transmission and can cluster within families. Eradication therapy for those who test positive helps reduce the source of infection and protect the health of their families.
In summary,helicobacter pylori is the only bacterium classified as a Class I carcinogen by the WHO. Detection of Helicobacter pylori is a key step in shifting from symptomatic treatment to causal treatment, and from post-treatment to pre-emptive prevention. It is crucial for maintaining long-term digestive tract health and even preventing gastric cancer.